Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.Circulation. 2006 Dec 12; 114(24):2710-38.Circ
Abstract
Although for most children the process of atherosclerosis is subclinical, dramatically accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary events occurring in childhood and very early adult life. As with most scientific statements about children and the future risk for cardiovascular disease, there are no randomized trials documenting the effects of risk reduction on hard clinical outcomes. A growing body of literature, however, identifies the importance of premature cardiovascular disease in the course of certain pediatric diagnoses and addresses the response to risk factor reduction. For this scientific statement, a panel of experts reviewed what is known about very premature cardiovascular disease in 8 high-risk pediatric diagnoses and, from the science base, developed practical recommendations for management of cardiovascular risk.
Links
MeSH
Arthritis, RheumatoidAtherosclerosisCardiovascular DiseasesChildChronic DiseaseDiabetes ComplicationsDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Evidence-Based MedicineHeart Defects, CongenitalHeart TransplantationHumansHyperlipoproteinemia Type IIKidney DiseasesLupus Erythematosus, SystemicMucocutaneous Lymph Node SyndromeNeoplasmsRisk FactorsRisk Reduction Behavior
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
17130340
Citation
Kavey, Rae-Ellen W., et al. "Cardiovascular Risk Reduction in High-risk Pediatric Patients: a Scientific Statement From the American Heart Association Expert Panel On Population and Prevention Science; the Councils On Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group On Quality of Care and Outcomes Research: Endorsed By the American Academy of Pediatrics." Circulation, vol. 114, no. 24, 2006, pp. 2710-38.
Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2006;114(24):2710-38.
Kavey, R. E., Allada, V., Daniels, S. R., Hayman, L. L., McCrindle, B. W., Newburger, J. W., Parekh, R. S., & Steinberger, J. (2006). Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation, 114(24), 2710-38.
Kavey RE, et al. Cardiovascular Risk Reduction in High-risk Pediatric Patients: a Scientific Statement From the American Heart Association Expert Panel On Population and Prevention Science; the Councils On Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group On Quality of Care and Outcomes Research: Endorsed By the American Academy of Pediatrics. Circulation. 2006 Dec 12;114(24):2710-38. PubMed PMID: 17130340.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.
AU - Kavey,Rae-Ellen W,
AU - Allada,Vivek,
AU - Daniels,Stephen R,
AU - Hayman,Laura L,
AU - McCrindle,Brian W,
AU - Newburger,Jane W,
AU - Parekh,Rulan S,
AU - Steinberger,Julia,
AU - ,,
AU - ,,
AU - ,,
AU - ,,
AU - ,,
AU - ,,
AU - ,,
AU - ,,
Y1 - 2006/11/27/
PY - 2006/11/30/pubmed
PY - 2007/1/4/medline
PY - 2006/11/30/entrez
SP - 2710
EP - 38
JF - Circulation
JO - Circulation
VL - 114
IS - 24
N2 - Although for most children the process of atherosclerosis is subclinical, dramatically accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary events occurring in childhood and very early adult life. As with most scientific statements about children and the future risk for cardiovascular disease, there are no randomized trials documenting the effects of risk reduction on hard clinical outcomes. A growing body of literature, however, identifies the importance of premature cardiovascular disease in the course of certain pediatric diagnoses and addresses the response to risk factor reduction. For this scientific statement, a panel of experts reviewed what is known about very premature cardiovascular disease in 8 high-risk pediatric diagnoses and, from the science base, developed practical recommendations for management of cardiovascular risk.
SN - 1524-4539
UR - https://www.unboundmedicine.com/medline/citation/17130340/full_citation
L2 - https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.106.179568?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed
DB - PRIME
DP - Unbound Medicine
ER -
